CEBP Infection and Cancer: Biology, Therapeutics, and Prevention 2008 Conference on Cancer Prevention - Washington, D.C.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roth, M. J.
Right arrow Articles by Taylor, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roth, M. J.
Right arrow Articles by Taylor, P. R.
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 1576-1578, June 2005
© 2005 American Association for Cancer Research

Null Results in Brief

Common Leptin Receptor Polymorphisms do not Modify the Effect of Alcohol Ingestion on Serum Leptin Levels in a Controlled Feeding and Alcohol Ingestion Study

Mark J. Roth1, Dina N. Paltoo5, Paul S. Albert2, David J. Baer6, Joseph T. Judd6, Joseph Tangrea3 and Philip R. Taylor4

1 Nutritional Epidemiology Branch, 2 Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, 3 Biometric Research Branch, Division of Cancer Treatment and Diagnosis, 4 Center for Cancer Research, National Cancer Institute, 5 Clinical and Molecular Medicine Program, National Heart, Lung, and Blood Institute, Bethesda, Maryland; and 6 Beltsville Human Nutrition Research Center, Department of Agriculture, Agricultural Research Service, Beltsville, Maryland

Requests for reprints: Mark J. Roth, Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Suite 705, MSC 8314, Bethesda, MD 20892. Phone: 301-402-8276; Fax: 301-435-8645. E-mail: mr166i{at}nih.gov


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We explored whether serum leptin response to alcohol ingestion was related to common leptin receptor gene polymorphisms, K109R (Lys109Arg), Q223R (Gln223Arg), S343S [Ser(T)343Ser(C)], and K656N (Lys656Asn), of reported physiologic significance during a controlled intervention. Fifty-three participants rotated through three 8-week treatment periods and consumed 0, 15 (equivalent to one drink), or 30 g (equivalent to two drinks) of alcohol (95% ethanol in 12 ounces of orange juice) per day, in random order. During the controlled feeding periods, all food and beverages including alcoholic beverages were prepared and supplied by the staff of the Beltsville Human Nutrition Research Center's Human Study Facility (Beltsville, MD), and energy intake was adjusted to maintain a constant weight. Blood was collected after an overnight fast on 3 separate days during the last week of each controlled feeding period and pooled for hormone analysis. Circulating serum leptin concentration was measured in duplicate by RIA and genotype analysis was done on DNA extracted from WBC using real-time PCR analysis amplification (TaqMan). Linear mixed models with a single random intercept reflecting a participant effect were used to estimate changes in serum leptin levels at 15 and 30 g of alcohol per day relative to 0 g of alcohol per day. No significant effects were found between common leptin receptor polymorphisms and serum leptin levels (P ≥ 0.26).


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Leptin is a hormone produced by the adipocyte ob gene, involved in energy balance, and may play a role in carcinogenesis and autoimmune disorders (1-15). We recently showed that moderate alcohol consumption (15-30 g of alcohol per day) increased serum leptin levels in postmenopausal women in a controlled feeding and alcohol ingestion study (1). In that study, 53 healthy, nonsmoking postmenopausal women completed a random-order, three-period crossover design in which each woman received zero (0 g of alcohol), one (15 g of alcohol), or two (30 g alcohol) drinks per day. After accounting for differences in body mass index, consumption of 15 or 30 g of alcohol per day increased serum leptin levels by 7.3% and 8.9%, respectively, over zero alcohol consumption, with younger women (i.e., 49-54 years); demonstrating a significantly stronger association of alcohol consumption level with the increase in serum leptin levels than older women (i.e., 55-79 years; 24.4% versus 3.7% for 30 g of alcohol per day relative to 0 g of alcohol, respectively).

To understand the potential mechanisms influencing serum leptin response to alcohol, we expanded our original findings to explore the leptin response to alcohol on common leptin receptor gene polymorphisms with reported physiologic significance, K109R (Lys109Arg), Q223R (Gln223Arg), S343S [Ser(T)343Ser(C)], and K656N (Lys656Asn; ref. 16). This is the first controlled feeding and alcohol ingestion study to examine variation in serum leptin response in relation to common polymorphisms of the leptin receptor.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
A detailed description of the Women's Alcohol Study has been previously reported (17). Briefly, each participant rotated through three 8-week treatment periods and consumed 0, 15 (equivalent to one drink), or 30 g (equivalent to two drinks) of alcohol per day in random order. Alcohol was supplied to each participant as 95% ethanol (Everclear; Pharmco Products, Brookfield, CT) in orange juice (12 ounces) 1 to 2 hours before bedtime. Each controlled feeding period was preceded by a 2- to 5-week washout period during which time the participant consumed no alcohol. During the controlled feeding periods, all food and beverages were prepared and supplied by the Beltsville Human Nutrition Research Center's Human Study Facility (Beltsville, MD). Study participants were weighed each weekday at the Beltsville facility, and energy intake was adjusted to maintain a constant weight. Blood was collected after an overnight fast on 3 separate days during the last week of each controlled feeding period and pooled for hormone analysis. Circulating serum leptin concentration was measured in duplicate by RIA (Human Leptin RIA Kit, Linco Research, St. Charles, MO) and quantified using a Cobra Quantum Gamma Counter (Packard Instruments, Downers Grove, IL). Genotyping analysis was done on DNA extracted from WBC using a PureGene kit (Gentra Systems, Inc., Minneapolis, MN) and real-time PCR analysis amplification (TaqMan). Serum leptin concentrations were transformed to the natural log scale to make inferences on relative change and to make outcomes more normally distributed. Linear mixed models with a single random intercept reflecting a participant effect were used to estimate changes in serum leptin levels at 15 and 30 g of alcohol per day relative to 0 g of alcohol per day. Alcohol (three factors) by gene (two factors) interactions were examined by including appropriate cross product terms in the model. Adjustments for body mass index and period effects were done/done by including these terms as fixed effects in the linear mixed model.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
The majority of participants in this study were homozygous for the common allele at Lys109Arg (66%), Ser343Ser (71%) and Lys656Asn (74%), but, for Gln223Arg, heterozygotes were the most common genotype (42%; Table 1). Due to the small number of individuals homozygous for the variant alleles, we examined the percentage of change in serum leptin concentration based upon a dichotomized genotype analysis which compared those homozygous for the common allele versus those heterozygous or homozygous for the variant allele.


View this table:
[in this window]
[in a new window]
  		Table 1. Distribution of four common polymorphisms of the leptin receptor gene among participants of the women's alcohol study (n = 53)

 
After adjusting for body mass index and period effect, there were no significant differences in the percent change in serum leptin concentration with zero versus one or two drinks per day for these four common polymorphisms in the leptin receptor gene [P ≥ 0.26, test of alcohol (three factors) by gene (two factors) based on a conditional F test; Table 2]. Power calculations were conducted based on an estimate of the within-subject variation obtained from the linear mixed model and performing a two-sample t test that compared change from zero to two drinks per day between homozygous common allele and heterozygous/homozygous variant allele groupings. The linear mixed model should provide increased power over this simple analysis. Assuming the distribution of Lys109Arg alleles presented in Table 1 and an overall change of 8.9% (in geometric mean) as shown in Table 2, we were able to detect a difference between a 1% increase for the homozygous common allele and a 26% increase for the heterozygous/homozygous variant allele category with 80% power. The power calculations corresponding to the allele distribution for Ser343Ser and Lys656Asn were similar to those reported for Lys109Arg. For Gln223Arg, where the allele distribution was very different from the other polymorphisms, we were able to detect a difference between a 5% decrease for the homozygous common allele and an 18% increase for the heterozygous/homozygous variant allele category with 80% power.


View this table:
[in this window]
[in a new window]
  		Table 2. Percent change in serum leptin concentration with zero versus one or two drinks per day by four common polymorphisms (dichotomized genotype) in the leptin receptor gene (n= 53)

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
Our recent finding that moderate alcohol consumption (15-30 g of alcohol per day) increased serum leptin levels is consistent with leptin's reported responsiveness to physiologic variation (18). This responsiveness may, in part, result from serum leptin binding to a membrane-associated leptin receptor with subsequent activation of the JAK-STAT signal transduction pathway and downstream STAT transcription factors, including several regulatory elements within the leptin promoter (18). The current study expanded our original findings to explore the leptin response to alcohol on common leptin receptor gene polymorphisms with reported physiologic significance. This includes increased adiposity (Arg223 variant; refs. 19-21), higher abdominal fat in postmenopausal women (Gln223Gln homozygotes or who carry the Asn656 allele; ref. 19), low body mass index and low systolic and diastolic blood pressure (Lys109Arg; ref. 22), and variation in fat mass [Ser(T)343Ser(C) (ref. 23) and Lys656Asn (ref. 20)]. The results of this controlled intervention study found no significant modification of the serum leptin response to controlled alcohol ingestion by four common leptin receptor polymorphisms. The small number of participants limits the findings of this exploratory pilot study; however, adequate power exists for detecting a moderate (20-25%) difference between allelic categories. These results are further strengthened by the experimental design of the original intervention that maintained each participant's body mass index through control of caloric intake and food composition intake for >6 months and represent the first report of potential effects of leptin receptor polymorphisms on serum leptin levels following alcohol consumption in a controlled feeding study.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 1/ 5/05; revised 2/15/05; accepted 3/16/05.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Roth MJ, Baer DJ, Albert PS, et al. Relationship between serum leptin levels alcohol consumption in a controlled feeding and alcohol ingestion study. J Natl Cancer Inst 2003;95:1722–5.[Abstract/Free Full Text]
  2. Chang S, Hursting SD, Contois JH, et al. Leptin and prostate cancer. Prostate 2001;46:62–7.[CrossRef][Medline]
  3. Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJH, Peppelenbosch MP. Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001;121:79–90.[CrossRef][Medline]
  4. Stattin P, Soderberg S, Hallmans G, et al. Leptin is associated with increased prostate cancer risk: a nested case-referent study. J Clin Endocrinol Metab 2001;86:1341–5.[Abstract/Free Full Text]
  5. Tessitore L, Vizio B, Jenkins O, et al. Leptin expression in colorectal and breast cancer patients. Int J Mol Med 2000;5:421–6.[Medline]
  6. Petridou E, Papadiamantis Y, Markopoulos C, Spanos E, Dessypris N, Trichopoulos D. Leptin and insulin growth factor I in relation to breast cancer. Cancer Causes Control 2000;11:383–8.[CrossRef][Medline]
  7. Rose DP, Gilhooly EM, Nixon DW. Adverse effects of obesity on breast cancer prognosis, and the biological action of leptin (review). Int J Oncol 2002;21:1285–92.[Medline]
  8. Hu X, Juneja SC, Maihle NJ, Cleary MP. Leptin—a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 2002;94:1704–11.[Abstract/Free Full Text]
  9. O'Brien SN, Welter BH, Price TM. Presence of leptin in breast cell lines and breast tumors. Biochem Biophys Res Commun 1999;259:695–8.[CrossRef][Medline]
  10. Laud K, Gourdou I, Pessemesse L, Peyrat JP, Dijane J. Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 2002;188:219–26.[CrossRef][Medline]
  11. Laud K, Gourdou I, Belair L, Keisler DH, Dijane J. Detection and regulation of leptin receptor mRNA in ovine mammary epithelial cells during pregnancy and lactation. FEBS Lett 1999;463:194–8.[CrossRef][Medline]
  12. Liu Z, Uesaka T, Watanabe H, Kato N. High fat diet enhances colonic cell proliferation and carcinogenesis in rats be elevating serum leptin. Int J Oncol 2001;19:1009–14.[Medline]
  13. Evereklioglu C, Bulbul M, Ozerol E, et al. Serum leptin concentrations is increased in patients with Behcet's syndrome and is correlated with disease activity. Br J Dermatol 2002;147:331–6.[CrossRef][Medline]
  14. Garcia-Gonzalez A, Gonzalez-Lopez L, Valera-Gonzalez IC, et al. Serum leptin levels in women with systemic lupus erythematosus. Rheumatol Int 2002;22:138–41.[CrossRef][Medline]
  15. Matarese G, La Cava A, Sanna V, et al. Balancing susceptibility to infection and autoimmunity: a role for leptin? Trends Immunol 2002;23:182–7.[CrossRef][Medline]
  16. Rosmond R. Association studies of genetic polymorphisms in central obesity: a critical review. Int J Obes Relat Metab Disord 2003;27:1141–51.[CrossRef][Medline]
  17. Dorgan JF, Baer DJ, Albert PS, et al. Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst 2001;93:710–5.[Abstract/Free Full Text]
  18. Ahima RS, Osei SY. Leptin signaling. Physiol Behav 2004;81:223–41.[CrossRef][Medline]
  19. Chagnon YC, Wilmore JH, Borecki IB, et al. Associations between the leptin receptor gene and adiposity in middle-aged Caucasian males from the HERITAGE family study. J Clin Endocrinol Metab 2000;85:29–34.[Abstract/Free Full Text]
  20. Wauters M, Mertens I, Rankinen T, Changnon M, Bouchard C, Van Gaal L. Leptin receptor gene polymorphisms are associated with insulin in obese women with impaired glucose tolerance. J Clin Endocrinol Metab 2001;86:3227–32.[Abstract/Free Full Text]
  21. Mattevi VS, Zembrzuski VM, Hutz MH. Association analysis of genes involved in the leptin signaling pathway with obesity in Brazil. Int J Obesity 2002;26:1179–83.
  22. Rosmond R, Chagnon YC, Holm G, et al. Hypertension in obesity and the leptin receptor gene locus. J Clin Endocrinol Metab 2000;85:3126–31.[Abstract/Free Full Text]
  23. Mammes O, Aubert R, Betoulle D, et al. LEPR gene polymorphisms: associations with overweight, fat mass and response to diet in women. Eur J Clin Invest 2001;31:398–404.[CrossRef][Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roth, M. J.
Right arrow Articles by Taylor, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roth, M. J.
Right arrow Articles by Taylor, P. R.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online